2 signals · bluesky, h1b_lca, newsapi +1 more
Scores are directional signals derived from aggregated public data — not verified findings or investment advice. Methodology
Signal-based estimates from public data — not verified assessments. Learn more
Some stress signals present but below significant thresholds.
Low risk signals — no significant operational or reputational pressure detected.
Nuvation Bio in the Oncology Biotech space registers relatively low workforce stress signals and low overall risk indicators based on 4 signals across 2 sources.
Signals for Nuvation Bio were collected from 2 sources. Aggregate signal sentiment appears broadly positive. The stress score stands at 23/100 with a risk score of 0/100. Signal coverage is sufficient to support a preliminary assessment.
What this means
Signals indicate a relatively stable workplace environment based on available data.
Nuvation Bio (NUVB) Upgraded to Buy: Here's Why finance.yahoo.com
Analysts’ Recent Ratings Changes for Nuvation Bio (NUVB) A number of firms have modified their ratings and price targets on shares of Nuvation Bio (NYSE: NUVB) recently: 7/27/2026 – Nuvation Bio had its price target raised by HC Wainwright from $17.00 to $21.00. They now have a “buy” rating on the…
Analysts’ Recent Ratings Changes for Nuvation Bio (NUVB) A number of firms have modified their ratings and price targets on shares of Nuvation Bio (NYSE: NUVB) recently: 7/27/2026 – Nuvation Bio had its price target raised by HC Wainwright from $17.00 to $21.00.
Oncology-focused biopharmaceutical company.
Based on 2 signals across 4 sources · snapshot 15 Sept 2026
Strong — enough signals from diverse sources to trust this score.
Overall community sentiment for Nuvation Bio is positive based on public signals as of 15 Sept 2026.
Limited coverage — score may shift as signals arrive.
Based on 2 signals across 4 sources
Scores are directional signals derived from public data — not certified assessments or recommendations. Confidence indicates data coverage, not accuracy. Learn how scores are calculated →
Derived from public sources such as news, filings, and reported events.
AI-generated from public signals — may be incomplete. Based on 4 recent signals.
This summary is generated from publicly available review and signal data. It is intended as an indicative overview only and should not be used as the sole basis for employment, investment, or business decisions. Signal volume and source diversity may limit representativeness.
AI summaries are generated from public signals and may not reflect the full picture.
Nuvation Bio stock jumps on safusidenib trial expansion plans Investing.com